- Home
- ANGO vs AVNS Comparison
ANGO vs AVNS Comparison
Compare ANGO & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANGO | AVNS |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.0M | 521.7M |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ANGO | AVNS |
|---|---|---|
| Price | $11.36 | $14.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.33 | N/A |
| AVG Volume (30 Days) | 363.5K | ★ 536.2K |
| Earning Date | 04-07-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.92 | 81.59 |
| EPS | ★ N/A | N/A |
| Revenue | $291,010,000.00 | ★ $701,200,000.00 |
| Revenue This Year | $9.11 | $3.28 |
| Revenue Next Year | $4.94 | $4.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.17 | 1.95 |
| 52 Week Low | $8.27 | $9.30 |
| 52 Week High | $13.99 | $15.68 |
Technical Indicators
Market Signals| Indicator | ANGO | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 50.82 |
| Support Level | $10.37 | $10.94 |
| Resistance Level | $11.92 | $15.68 |
| Average True Range (ATR) | 0.40 | 0.61 |
| MACD | 0.10 | -0.16 |
| Stochastic Oscillator | 71.92 | 29.15 |
Price Performance
Historical ComparisonAbout ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.